Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan-Dec:27:2515690X221113330.
doi: 10.1177/2515690X221113330.

A 30-Day Adjunct Wellness Intervention for the Management of Extra-Articular Symptoms of Rheumatoid Arthritis: A Formative Study

Tara Hutson  1 , Nicole Murman  1 , Donna Rolin  1 , Rakesh Jain  2 , Andrew J Laster  3 , Steven P Cole  4 , Saundra Jain  1
Affiliations

A 30-Day Adjunct Wellness Intervention for the Management of Extra-Articular Symptoms of Rheumatoid Arthritis: A Formative Study

Tara Hutson et al. J Evid Based Integr Med. 2022 Jan-Dec.

Abstract

Individuals with rheumatoid arthritis (RA) continually fall short of treatment targets using standard drug therapies alone. There is growing evidence that emphasizing physical and mental wellness is equally crucial for improving functioning among people with RA. The purpose of this formative study is to examine the feasibility of offering the wellness-based intervention ("KickStart30") in patients with RA. Thirteen individuals with RA on targeted immune modulators (a biologic or JAK inhibitor) enrolled in the KickStart30 program. Participants completed self-report measures of RA-specific disability (eg, pain) and other functional areas (eg, mood) in a pre- versus post- intervention design. Paired samples t-tests (and Related-Samples Wilcoxon Signed Rank Tests for non-normal distributions) detected statistically significant results for 10 of 12 measures, including reductions in pain (M = 4.54 to M = 3.54; p = .025; BPI), functional disability (M = 0.94 to M = 0.73, p = .032; HAQ-II), cognitive and physical dysfunction (M = 25.46 to M = 13.54, p < .001; CPFQ), depressive symptoms (M = 9.31 to M = 5.54, p = .003; PHQ-9), anxiety (M = 5.69 to M = 3.23, p = .005; GAD-7), insomnia (M = 11.62 to M = 17.32, p = .007; Note: higher scores on the SCI indicate less insomnia), stress-related eating (M = 75.46 to M = 84.54, p = .021; Note: higher scores on the EADES indicate less stress-related eating), along with significant increases in mindfulness (M = 62.54 to M = 67.85, p = .040; MAAS), mental wellness (M = 4.46 to M = 5.69; HERO), and well-being (Md = 8.00 to Md = 5.00, p = .004; WHO-5). All significant measures had medium to large effect sizes (Cohen's d). The study gives preliminary support for the possibility that the adjunct intervention may have an effect.

Keywords: holistic medicine; mind-body; rheumatoid arthritis.

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting Interests: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Rakesh Jain - Co-creator of WILD5 Wellness Program – All profits are donated to mental health charitiesAndrew J. Laster - Consultants: Eli Lilly; Amgen; Myriad; Speaker bureau: Amgen; Eli Lilly; Pfizer; Novartis; Genentech; Exagen; MyriadSaundra Jain - Co-creator of WILD5 Wellness Program – All profits are donated to mental health charities; has served as a consultant, member of advisory boards, and/or speaker bureaus for Eli Lilly, Otsuka, Pamlab and Sunovion

References

    1. American College of Rheumatology. Statistics. Accessed June 6, 2020. https://www.rheumatology.org/Learning-Center/Statistics.
    1. England BR, Thiele GM, Anderson DR, Mikuls TR. Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications. Br Med J. 2018;361:k1036. 10.1136/bmj.k1036 - DOI - PMC - PubMed
    1. Theander L, Nyhall-Wahlin BM, Nilsson JA, et al. Severe extraarticular manifestations in a community-based cohort of patients with rheumatoid arthritis: risk factors and incidence in relation to treatment with tumor necrosis factor inhibitors. J Rheumatol. 2017;44(7):981-987. 10.3899/jrheum.161103 - DOI - PubMed
    1. Scott DL, Wolfe F, Huizinga TW. Rheumatoid arthritis. Lancet. 2010;376(9746):1094-1108. 10.1016/s0140-6736(10)60826-4 - DOI - PubMed
    1. Cutolo M, Kitas GD, van Riel PL. Burden of disease in treated rheumatoid arthritis patients: going beyond the joint. Semin Arthritis Rheum. 2014;43(4):479-488. 10.1016/j.semarthrit.2013.08.004 - DOI - PubMed

Publication types